{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T18:46:01Z","timestamp":1758393961780},"reference-count":46,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.prostaglandins.2005.12.003","type":"journal-article","created":{"date-parts":[[2006,1,28]],"date-time":"2006-01-28T07:10:36Z","timestamp":1138432236000},"page":"114-125","source":"Crossref","is-referenced-by-count":18,"title":["Co-localization of COX-2, CYP4F8, and mPGES-1 in epidermis with prominent expression of CYP4F8 mRNA in psoriatic lesions"],"prefix":"10.1016","volume":"79","author":[{"given":"Katarina","family":"Stark","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"T\u00f6rm\u00e4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernst H.","family":"Oliw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2005.12.003_bib1","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMra041320","article-title":"Psoriasis","volume":"352","author":"Sch\u00f6n","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib2","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/BF02976988","article-title":"Biological significance of essential fatty acids\/prostanoids\/lipoxygenase-derived monohydroxy fatty acids in the skin","volume":"25","author":"Ziboh","year":"2002","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib3","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","article-title":"Prostaglandins and leukotrienes: advances in eicosanoid biology","volume":"294","author":"Funk","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0090-6980(02)00025-4","article-title":"The enzymology of prostaglandin endoperoxide H synthases-1 and -2","volume":"68\u201369","author":"Smith","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/excr.1996.0113","article-title":"Cyclooxygenases in human and mouse skin and cultured human keratinocytes: association of COX-2 expression with human keratinocyte differentiation","volume":"224","author":"Leong","year":"1996","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib6","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.brainresrev.2004.12.024","article-title":"New insights into COX-2 biology and inhibition","volume":"48","author":"Patrignani","year":"2005","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib7","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1046\/j.1523-1747.2003.12495.x","article-title":"Epidermal COX-2 induction following ultraviolet irradiation: suggested mechanism for the role of COX-2 inhibition in photoprotection","volume":"121","author":"Tripp","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib8","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1046\/j.1523-1747.2003.12354.x","article-title":"Quantitative real-time reverse transcription-polymerase chain reaction analysis of drug metabolizing and cytoprotective genes in psoriasis and regulation by ultraviolet radiation","volume":"121","author":"Smith","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib9","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbrc.2005.08.152","article-title":"Coupling between cyclooxygenases and terminal prostanoid synthases","volume":"338","author":"Ueno","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0163-7827(94)90029-9","article-title":"Oxygenation of polyunsaturated fatty acids by cytochrome P450 monooxygenases","volume":"33","author":"Oliw","year":"1994","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib11","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(02)11203-7","article-title":"Clinical importance of the cytochromes P450","volume":"360","author":"Nebert","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.0022-202X.2004.23307.x","article-title":"Cytochrome p450: a target for drug development for skin diseases","volume":"123","author":"Ahmad","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cbi.2004.08.006","article-title":"Cytochrome P450 expression in human keratinocytes: an aryl hydrocarbon receptor perspective","volume":"149","author":"Swanson","year":"2004","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.taap.2003.09.020","article-title":"Epidermal CYP2 family cytochromes P450","volume":"195","author":"Du","year":"2004","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib15","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.tibs.2004.10.005","article-title":"Enzymes involved in the activation and inactivation of vitamin D","volume":"29","author":"Prosser","year":"2004","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib16","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0140-6736(03)13081-4","article-title":"Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases","volume":"361","author":"Smith","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib17","doi-asserted-by":"crossref","first-page":"18538","DOI":"10.1074\/jbc.272.30.18538","article-title":"cDNA cloning of human retinoic acid-metabolizing enzyme (hP450RAI) identifies a novel family of cytochromes P450","volume":"272","author":"White","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0090-6980(02)00039-4","article-title":"Prostaglandin and leukotriene omega-hydroxylases","volume":"68\u201369","author":"Kikuta","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib19","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2133.2001.04490.x","article-title":"Cytochrome P450 4A11 expression in human keratinocytes: effects of ultraviolet irradiation","volume":"145","author":"Gonzalez","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib20","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0003-9861(02)00511-8","article-title":"Expression of CYP4F8 (prostaglandin H 19-hydroxylase) in human epithelia and prominent induction in epidermis of psoriatic lesions","volume":"409","author":"Stark","year":"2003","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib21","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1046\/j.1523-1747.2003.12124.x","article-title":"Allelic variants of drug metabolizing enzymes as risk factors in psoriasis","volume":"120","author":"Richter-Hintz","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib22","doi-asserted-by":"crossref","first-page":"21844","DOI":"10.1074\/jbc.M001712200","article-title":"Identification of CYP4F8 in human seminal vesicles as a prominent 19-hydroxylase of prostaglandin endoperoxides","volume":"275","author":"Bylund","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib23","doi-asserted-by":"crossref","first-page":"7220","DOI":"10.1073\/pnas.96.13.7220","article-title":"Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target","author":"Jakobsson","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib24","doi-asserted-by":"crossref","first-page":"32783","DOI":"10.1074\/jbc.M003505200","article-title":"Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2","volume":"275","author":"Murakami","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.prostaglandins.2004.09.014","article-title":"On the mechanism of biosynthesis of 19-hydroxyprostaglandins of human seminal fluid and expression of cyclooxygenase-2, PGH 19-hydroxylase (CYP4F8) and microsomal PGE synthase-1 in seminal vesicles and vas deferens","volume":"75","author":"Stark","year":"2005","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1365-2605.1999.00142.x","article-title":"Immunomodulators in human seminal plasma: a vital protection for spermatozoa in the presence of infection?","volume":"22","author":"Kelly","year":"1999","journal-title":"Int J Androl"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib27","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1210\/en.143.6.2410","article-title":"Immunohistochemical localization of microsomal PGE synthase-1 and cyclooxygenases in male mouse reproductive organs","volume":"143","author":"Lazarus","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib28","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.abb.2005.07.003","article-title":"Oxygenation of polyunsaturated long chain fatty acids by recombinant CYP4F8 and CYP4F12 and catalytic importance of Tyr-125 and Gly-328 of CYP4F8","volume":"441","author":"Stark","year":"2005","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib29","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2133.1993.tb03163.x","article-title":"An in vivo experimental model for effects of topical retinoic acid in human skin","volume":"129","author":"Griffiths","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/bbrc.1999.1011","article-title":"Gene expression of a novel cytochrome P450 of the CYP4F subfamily in human seminal vesicles","volume":"261","author":"Bylund","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib31","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1006\/bbrc.2000.4191","article-title":"cDNA cloning and expression of CYP4F12, a novel human cytochrome P450","volume":"280","author":"Bylund","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib32","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1248\/yakushi.123.369","article-title":"Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR","volume":"123","author":"Nishimura","year":"2003","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib33","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/000155500750012405","article-title":"Decreased mRNA levels of retinoic acid receptor alpha, retinoid X receptor alpha and thyroid hormone receptor alpha in lesional psoriatic skin","volume":"80","author":"T\u00f6rm\u00e4","year":"2000","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib34","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1742-7843.2004.pto940404.x","article-title":"Expression of CYP4F12 in gastrointestinal and urogenital epithelia","volume":"94","author":"Stark","year":"2004","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib35","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ab.2005.01.036","article-title":"The benefits of 28S rRNA for standardization of reverse transcription-polymerase chain reaction for studying gene expression","volume":"341","author":"Denz","year":"2005","journal-title":"Anal Biochem"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib36","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0090-6980(93)90102-D","article-title":"Identification of 19 (R)-OH prostaglandin E2 as a selective prostanoid EP2-receptor agonist","volume":"46","author":"Woodward","year":"1993","journal-title":"Prostaglandins"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.lfs.2003.09.031","article-title":"EP2 and EP4 prostanoid receptor signaling","volume":"74","author":"Regan","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib38","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0167-4889(97)00114-6","article-title":"Growth regulation of primary human keratinocytes by prostaglandin E receptor EP2 and EP3 subtypes","volume":"1401","author":"Konger","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1189\/jlb.1203627","article-title":"Prostaglandin E2 receptors EP2 and EP4 are up-regulated in peritoneal macrophages and joints of pristane-treated mice and modulate TNF-alpha and IL-6 production","volume":"76","author":"Akaogi","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib40","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1365-2133.2005.06781.x","article-title":"Diet and psoriasis: experimental data and clinical evidence","volume":"153","author":"Wolters","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib41","doi-asserted-by":"crossref","first-page":"9279","DOI":"10.1074\/jbc.273.15.9279","article-title":"A keratinocyte-specific epoxygenase, CYP2B12, metabolizes arachidonic acid with unusual selectivity, producing a single major epoxyeicosatrienoic acid","volume":"273","author":"Keeney","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib42","doi-asserted-by":"crossref","first-page":"32071","DOI":"10.1074\/jbc.273.48.32071","article-title":"Differentiating keratinocytes express a novel cytochrome P450 enzyme, CYP2B19, having arachidonate monooxygenase activity","volume":"273","author":"Keeney","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib43","doi-asserted-by":"crossref","first-page":"35184","DOI":"10.1074\/jbc.M301666200","article-title":"Epoxyeicosatrienoic acids activate transglutaminases in situ and induce cornification of epidermal keratinocytes","volume":"278","author":"Ladd","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bbalip.2004.03.007","article-title":"Expression and induction of CYP4F subfamily in human leukocytes and HL60 cells","volume":"1683","author":"Kikuta","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib45","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.bbrc.2003.12.062","article-title":"Induction of cytochrome CYP4F3A in all-trans-retinoic acid-treated HL60 cells","volume":"314","author":"Mizukami","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.prostaglandins.2005.12.003_bib46","doi-asserted-by":"crossref","first-page":"D91","DOI":"10.1093\/nar\/gki103","article-title":"The MAPPER database: a multi-genome catalog of putative transcription factor binding sites","volume":"33","author":"Marinescu","year":"2005","journal-title":"Nucleic Acids Res"}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882305001462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882305001462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T14:50:00Z","timestamp":1547823000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882305001462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":46,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S1098882305001462"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2005.12.003","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}